Literature DB >> 9261095

Characterization of the interactions between PDZ domains of the protein-tyrosine phosphatase PTPL1 and the carboxyl-terminal tail of Fas.

J Saras1, U Engström, L J Góñez, C H Heldin.   

Abstract

The intracellular protein-tyrosine phosphatase PTPL1 has five PDZ domains and one of them, PDZ 2, has previously been shown to interact with the C-terminal tail of Fas, a member of the tumor necrosis factor receptor family. Using a peptide binding assay, we show that not only PDZ 2 but also PDZ 4 of PTPL1 interacts with high affinity with peptides derived from the C terminus of Fas. The five most C-terminal amino acid residues of Fas influence the affinity of the interaction. Whereas the glutamine and isoleucine residues in the 4th and 5th positions from the C terminus affect the interaction in a negative and positive manner, respectively, the three C-terminal amino acid residues (SLV) are necessary and sufficient for a high affinity interaction to occur. Both the carboxyl group and side chain of the valine residue at the C terminus of Fas are essential, and the leucine and serine residues in the 2nd and 3rd positions, respectively, from the C terminus are important for the interactions with PDZ 2 and PDZ 4 of PTPL1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261095     DOI: 10.1074/jbc.272.34.20979

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  C terminus of presenilin is required for overproduction of amyloidogenic Abeta42 through stabilization and endoproteolysis of presenilin.

Authors:  T Tomita; R Takikawa; A Koyama; Y Morohashi; N Takasugi; T C Saido; K Maruyama; T Iwatsubo
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  The interaction of PTP-BL PDZ domains with RIL: an enigmatic role for the RIL LIM domain.

Authors:  Lieke C J van den Berk; Marco A van Ham; Mariska M te Lindert; Tine Walma; Jan Aelen; Geerten W Vuister; Wiljan J A J Hendriks
Journal:  Mol Biol Rep       Date:  2004-12       Impact factor: 2.316

3.  PDZ motifs in PTP-BL and RIL bind to internal protein segments in the LIM domain protein RIL.

Authors:  E Cuppen; H Gerrits; B Pepers; B Wieringa; W Hendriks
Journal:  Mol Biol Cell       Date:  1998-03       Impact factor: 4.138

4.  FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS.

Authors:  Erik D Foehr; Gustavo Lorente; Valerie Vincent; Karoly Nikolich; Roman Urfer
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 5.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

6.  Promiscuous binding at the crossroads of numerous cancer pathways: insight from the binding of glutaminase interacting protein with glutaminase L.

Authors:  David L Zoetewey; Mohiuddin Ovee; Monimoy Banerjee; Rajagopalan Bhaskaran; Smita Mohanty
Journal:  Biochemistry       Date:  2011-04-06       Impact factor: 3.162

7.  GIPC proteins negatively modulate Plexind1 signaling during vascular development.

Authors:  Jorge Carretero-Ortega; Zinal Chhangawala; Shane Hunt; Carlos Narvaez; Javier Menéndez-González; Carl M Gay; Tomasz Zygmunt; Xiaochun Li; Jesús Torres-Vázquez
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

8.  FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface.

Authors:  Vladimir N Ivanov; Pablo Lopez Bergami; Gabriel Maulit; Taka-Aki Sato; David Sassoon; Ze'ev Ronai
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

9.  Association of protein-tyrosine phosphatase PTP-BAS with the transcription-factor-inhibitory protein IkappaBalpha through interaction between the PDZ1 domain and ankyrin repeats.

Authors:  K Maekawa; N Imagawa; A Naito; S Harada; O Yoshie; S Takagi
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

10.  Fas-associated phosphatase 1 (Fap1) influences βcatenin activity in myeloid progenitor cells expressing the Bcr-abl oncogene.

Authors:  Weiqi Huang; Ling Bei; Elizabeth A Eklund
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.